Eli Lilly and Company (LLY) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 965.06B |
| Enterprise Value | 1T |
| P/E Ratio | 45.89 |
| PEG Ratio | 0.91 |
| Price/Sales Ratio | 15.42 |
| Price/Book Ratio | 31.39 |
| Enterprise/Revenue | 15.94 |
| Enterprise/EBITDA | 30.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.32 |
| Operating Margin | 0.46 |
| Return On Assets | 0.19 |
| Return On Equity | 0.84 |
| Revenue | 65.18B |
| Revenue/Share | 96.94 |
| Gross Profit | 54.13B |
| EBITDA | 31.69B |
| Net Income | 20.64B |
| Diluted EPS | 22.95 |
| Total Cash | 4.89B |
| Total Cash/Share | 5.48 |
| Total Debt | 49.5B |
| Total Debt/Equity | 1.23 |
| Current Ratio | 1.39 |
| Book Value Per Share | 45.15 |
| 52-Week Change | 58.11 |
| 52-Week High | 1,449.68 |
| 52-Week Low | 850.51 |
| Moving Average 50 Days | 1,197.14 |
| Moving Average 200 Days | 1,091.24 |
| Average Volume | 2.55M |
| Shares Outstanding | 940.75M |
| % Held by Institutions | 88.92 |
| Trailing Annual Dividend Rate | 6.69 |
| Trailing Annual Dividend Yield | 0.47 |
| Payout Ratio | 0.22 |
| Last Split Factor | 2:1 |
| Last Split Date | October 16, 1997 |